Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. [electronic resource]
- Transplantation proceedings Nov 2016
- 3106-3108 p. digital
Publication Type: Case Reports; Journal Article
1873-2623
10.1016/j.transproceed.2016.04.005 doi
Abatacept--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Atypical Hemolytic Uremic Syndrome--complications Calcineurin Inhibitors--adverse effects Humans Immunosuppressive Agents--therapeutic use Kidney Transplantation--adverse effects Male Plasmapheresis--adverse effects Postoperative Complications--chemically induced Thrombotic Microangiopathies--chemically induced Young Adult